06/11/2025
5:01 AM | Applied Therapeutics (Issuer)
SKYLER JAY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
5:01 AM | Applied Therapeutics (Issuer)
Kanter Stacy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
5:01 AM | Applied Therapeutics (Issuer)
Lerner Teena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
4:46 PM | Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
9:19 AM | Applied Therapeutics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G | |
05/07/2025
9:37 AM | Applied Therapeutics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/28/2025
3:35 PM | Applied Therapeutics (Filer)
| Form DEF 14A | |
04/28/2025
3:38 PM | Applied Therapeutics (Filer)
| Form DEFA14A | |
04/28/2025
3:40 PM | Applied Therapeutics (Filer)
| Form ARS | |
03/31/2025
6:00 AM | Applied Therapeutics (Filer)
| Form NT 10-K | |
03/26/2025
7:25 PM | Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for APLT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Applied Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/26/2025
7:14 PM | Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
7:21 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:30 PM | Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:30 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:30 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:11 PM | Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
3:30 PM | Alyeska Investment Group, L.P. (Filed by)
Applied Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/14/2025
3:15 PM | Applied Therapeutics (Subject)
Schonfeld Strategic Advisors LLC (Filed by)
| Form SCHEDULE 13G | |
02/14/2025
1:35 PM | Applied Therapeutics (Subject)
Vestal Point Capital, LP (Filed by)
| Form SCHEDULE 13G | |
02/14/2025
10:36 AM | Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
7:30 PM | Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
7:30 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
7:30 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
4:28 PM | Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
2:30 PM | Applied Therapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
11:48 AM | Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
12/20/2024
7:30 PM | Applied Therapeutics (Issuer)
JOHNSON JOHN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/20/2024
7:30 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
7:30 PM | Applied Therapeutics (Issuer)
JOHNSON JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
6:07 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
10:36 AM | Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
12/02/2024
4:15 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:47 PM | Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
3:50 PM | Applied Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:15 PM | ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by)
Applied Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
11/07/2024
6:30 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:19 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:38 PM | Applied Therapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
10/31/2024
11:42 AM | Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad) Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.”
We recently sat down with Rickards to capture all the key details on tape.
 For the moment, you can watch this interview free of charge – just click here. |
10/24/2024
1:02 PM | Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
08/23/2024
3:33 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:35 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:52 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
| Form SC 13D/A | |
08/14/2024
6:01 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
7:43 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
6:08 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:13 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
